Answers are grounded in this paper and cite their sources.
The genus Streptococcus consists of diverse bacteria that are integral components of the human microbiome, acting as both important commensals and opportunistic pathogens. In this study, one strain of an α-hemolytic species of the genus Streptococcus, GP0011T, isolated from an esophageal aspirate collected during an endoscopy, was characterised phenotypically to establish its taxonomic status. The strain was isolated from an adult male heterozygous for a cystic fibrosis transmembrane conductance regulator (CFTR) mutation. The phylogenetic analysis indicates that the strain is a novel species within the mitis group, with Streptococcus oralis ATCC 35037T being the closest relative with 94.84% average nucleotide identity (ANI) and 58.3% digital DNA-DNA hybridization (dDDH). Phenotypic characterization and API20 Strep strips distinguished GP0011T from S. oralis by the absence of alkaline phosphatase activity, trehalose fermentation, and starch fermentation, and by superior growth on D-mannitol and D-sorbitol, consistent with genomic data. The strain is Gram-positive, catalase-negative, and the cells are ovoid with a mean cell diameter of 1.3 µm. Growth occurred at 25-43 C, with an optimum at 30 C, with an optimum at pH 8.0. Antibiotic resistance genes msrD and mefA, conferring resistance to azithromycin and erythromycin, as well as pathways for mannitol and sorbitol metabolism, were found and phenotypically confirmed in the GP0011T genome but were absent from S. oralis. These findings indicate that GP0011T represents a novel species within the genus Streptococcus with the proposed name of Streptococcus ruoffae sp. nov. The type strain is GP0011T (ATCC TSD-627 and NCTC 15312).
No takes yet. Share an insight, caveat, or question.
Abrahamson et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: